GleamWall
中文EN

CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Services-Commercial Physical & Biological Research · NYSE · SEC CIK 1100682 · Fiscal year ends 12/27

Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-1.2%
TTM net income YoY148.8%
TTM EPS YoY160.5%
Revenue 3-yr CAGR-1.9%
Net income 3-yr CAGR-56.1%

Margins

Gross margin—
Operating margin4.0%
Net margin1.0%
FCF margin10.0%
EBITDA margin11.2%

Returns

ROE1.2%
ROA0.5%
ROIC (approx.)2.3%
Asset turnover0.53x

Leverage & solvency

Liabilities / assets56.0%
Debt / equity0.76x
Current ratio1.41x
Interest coverage1.45x

Cash quality & payout

Operating cash flow / net income15.49x
Accruals ratio-7.8%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-27FY20242024-12-28
Income statement
Revenue$4.02B$4.05B
SG&A expense$743.07M$751.00M
Operating income$25.16M$227.35M
Interest expense$107.03M$126.29M
Pretax income-$99.50M$93.11M
Income tax$42.66M$67.82M
Net income-$144.34M$22.20M
EBITDA$428.47M$589.09M
EPS (basic)-2.910.20
EPS (diluted)-2.910.20
Weighted avg. shares (diluted)49.56M51.63M
Balance sheet
Cash & equivalents$213.77M$205.57M
Receivables$708.86M$720.91M
Inventory$299.10M$278.54M
Current assets$1.45B$1.40B
PP&E, net$1.66B$1.60B
Goodwill$2.76B$2.85B
Intangibles$340.00M$723.40M
Total assets$7.14B$7.53B
Current liabilities$1.12B$994.10M
Short-term debt$166,000$155,000
Long-term debt$2.14B$2.24B
Total debt$2.14B$2.24B
Total liabilities$3.92B$4.02B
Shareholders' equity$3.16B$3.46B
Net debt$1.92B$2.03B
Shares outstanding49.22M51.14M
Cash flow statement
Operating cash flow$737.65M$734.58M
Capital expenditure$219.15M$232.97M
Free cash flow$518.49M$501.61M
Investing cash flow-$209.32M-$245.09M
Financing cash flow-$536.73M-$550.93M
Depreciation & amortization$403.31M$361.74M
Stock-based compensation$71.08M$69.89M
Share buybacks$360.67M$119.17M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.